MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    A healthy volunteer phase 1 study of RE-024, a potential phosphopantothenate replacement therapy for patients with pantothenate kinase-associated neurodegeneration (PKAN)

    R.D. Marshall, A. Harring-Abbott, K. Lucey, K. Leach, M. Beconi, J. Hunt, H. Plotkin (San Diego, CA, USA)

    Objective: To assess the safety, tolerability, and pharmacokinetics of single oral doses of RE-024 in healthy adult volunteers. Background: PKAN is a rare, autosomal recessive,…
  • 2016 International Congress

    Objectivisation of postural disorders in patients with Parkinson’s disease during the screening stage for DBS

    A.G. Buniak, I.P. Maryenko, S.A. Likhachev (Minsk, Belarus)

    Objective: Objectivisation of degree of postural disorders in PD patients during the screening stage for DBS. Background: The neurosurgical treatment of Parkinson's disease (PD) using…
  • 2016 International Congress

    Is inter-limb coupling modified by subthalamic deep brain stimulation and dopaminergic medication in Parkinson’s disease?

    C. Duval, J.F. Daneault, A.F. Sadikot (Montréal, QC, Canada)

    Objective: We characterized different aspects of bimanual coordination in patients with PD, including inter-limb coupling, and then determined whether they were altered by therapeutic modulation…
  • 2016 International Congress

    Deep brain stimulation in the STN of a Parkinsonian rat model overexpressing human A53T α-synuclein in the substantia nigra – A proof of principle

    T. Musacchio, M. Rebenstorff, F. Fluri, C. Kleinschnitz, J.M. Brotchie, J. Volkmann, J.B. Koprich, C.W. Ip (Würzburg, Germany)

    Objective: To determine if subthalamic nucleus (STN)-deep brain stimulation (DBS) leads to a measurable functional improvement of motor deficits in an AAV1/2 A53T α-synuclein (aSyn)…
  • 2016 International Congress

    Is awake intraoperative mapping still necessary for bilateral subthalamic stimulation for Parkinson’s disease in a modern surgical environment?

    Y. Zouitina, M. Lefranc, P. Merle, O. Godefroy, M. Tir, P. Krystkowiak (Amiens, France)

    Objective: To study the impact of the absence of awake clinical evaluation during subthalamic nucleus (STN) deep brain stimulation (DBS) on parameters of stimulation and…
  • 2016 International Congress

    Idiopathic delayed-onset edema surrounding deep brain stimulation leads: Insights from a case series and systematic literature review

    C.M.K.E. de Cuba, A. Albanese, A. Antonini, G. Cossu, G. Deuschl, R. Eleopra, A. Galati, C.F.E. Hoffman, K. Knudsen, A. Landi, M.M.R. Lanotte, A. Marcante, A. Mosch, M. Pilleri, M.M. Reich, V. Ricchi, S. Rinaldo, L.M. Romito, F. Saba, H.E. Sacristan, P.R. Schuurman, A. Trezza, P. van den Munckhof, J. Volkmann, M. Zibetti, M.F. Contarino (Amsterdam, Netherlands)

    Objective: We present a multicenter case series of patients with idiopathic delayed-onset edema (IDE) surrounding the deep brain stimulation (DBS) leads, and a systematic literature…
  • 2016 International Congress

    Autonomic failure and circadian rhythm of arterial blood pressure in IDIOPATHIC REM behaviour disorders and Parkinson’s disease

    R. Zangaglia, E. Guaschino, N. Ghiotto, B. Minafra, M. Terzaghi, G. Capone, A. Spiritelli, D. Bosone, C. Pacchetti (Pavia, Italy)

    Objective: Aim of our study is to correlate the autonomic nervous system failure and circadian rhythm of arterial blood pressure in idiopathic REM behaviour disorders…
  • 2016 International Congress

    Vitamin D in early Parkinson’s disease

    I.M. Sleeman, T. Aspray, S. Coleman, G. Duncan, T.K. Khoo, I. Schoenmakers, L. Rochester, D.J. Burn, A.J. Yarnall (Newcastle, United Kingdom)

    Objective: To determine serum 25-hydroxy vitamin D (25OHD) concentration at diagnosis and 18 months in incident Parkinson's disease (PD) compared to controls and to investigate…
  • 2016 International Congress

    Subjective report does not predict objective swallow impairment in atypical Parkinsonian syndromes

    L. Shahgholi, S. De Jesus, A. Paterson, W. Deeb, N.R. McFarland, K. Hegland (Gainesville, FL, USA)

    Objective: Swallow and speech disturbances are common in patients with atypical parkinsonism. The emergence of swallowing problems, or dysphagia, is associated with increased morbidity and…
  • 2016 International Congress

    Composite autonomic symptom scale-31 (COMPASS-31) is useful for evaluation of autonomic dysfunction in patients with parkinsonism

    Y. Kim, J.M. Seok, H.J. Kim, J. Youn, B.J. Kim, J.W. Cho (Seoul, Korea)

    Objective: To investigate the usefulness of composite autonomic symptom scale 31 (COMPASS-31) in patients with parkinsonism by comparing COMPASS-31 between PD and MSA patients, and…
  • « Previous Page
  • 1
  • …
  • 385
  • 386
  • 387
  • 388
  • 389
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley